Showing 111 of 111on this page. Filters & sort apply to loaded results; URL updates for sharing.111 of 111 on this page
Achaogen справилась с испытаниями нового антибиотика | МОСМЕДПРЕПАРАТЫ
Achaogen files for bankruptcy protection, seeks asset sale | BioPharma Dive
Achaogen 2017 Q2 - Results - Earnings Call Slides (OTCMKTS:AKAOQ ...
Achaogen - Crunchbase Company Profile & Funding
Achaogen Inc - ZIP 94080, NAICS 541715, SIC 8731
Achaogen sold the global assets to Cipla USA
Cipla USA acquires anti-infective Zemdri from Achaogen Inc, Health News ...
Achaogen slowly soars, speeding top antibiotic to FDA/EMA after PhIII ...
Achaogen Provides Data to SPARK, Pew’s Platform for Antibiotic ...
Achaogen wields ax on R&D, C-suite as antibiotic launch gets underway ...
Achaogen Logo FDA Hands Achaogen Split Approval And Rejection For
Achaogen Wins up to $64M BARDA Contract to Develop Antibiotic for ...
Achaogen Lab Improvements | SC Builders Inc.
Achaogen Taps New Buyer for Antibacterial Drug Rights - WSJ
Achaogen AKAO New Antibiotic in Phase 3 - IPO Candy
BARDA, Achaogen partner to develop antibiotic to combat infections from ...
Achaogen to Sell Drug Rights, Lab Equipment for $16 Million - WSJ
Achaogen Office Photos
Achaogen « New Drug Approvals
Why antibiotic developer Achaogen (NASDAQ: AKAO) fell — and why its ...
Achaogen to share data from discontinued antibiotic program | CIDRAP
Achaogen Leases New Headquarters at Genesis Tower in South San Francisco
Achaogen bankruptcy raises worry over antibiotic pipeline | CIDRAP
Achaogen Begins Phase 3 Trial For New Antibiotic Plazomicin
Achaogen Boosted by Unique Antibiotic Plan - Barron's
Achaogen Inc. (fka AKAOQ) : $AKAOQ: Maybe Sihuan Pharma takes over.....
Achaogen Eliminating 80 Jobs, 28% of Staff, in Restructuring
Blake Wise Achaogen
Achaogen seeks near-term sale through bankruptcy process | Fierce Biotech
Marquette AIM Program Blog: An AIM holding: Achaogen (AKAO) by Jack O ...
Achaogen to join life sciences IPOs next week - San Francisco Business ...
New OnePager Case Study: Achaogen - OnePager BlogOnePager Blog
Achaogen Stock Could Surge to $10 | Barron's
shuang wu - scientist at Achaogen | The Org
Achaogen Stock Could Surge to $10 - Barron's
Antibiotic developer Achaogen files for bankruptcy
How Genesis tower landed its 1st biotech tenant in Achaogen (NASDAQ ...
Achaogen Bankruptcy Bills About $3 Million Before Filing - WSJ
Should You Avoid Achaogen Inc (AKAO)? - Insider Monkey
Achaogen (AKAOQ) Stock Price, News & Analysis
Achaogen
Achaogen Case Study | OnePager
Our Portfolio - Strategic Investment Fund
Hear from Our Clients — LevelUp EQ
Portfolio - Arch Venture Partners
今こそ抗菌薬市場を是正すべき時...
cUTI « New Drug Approvals
Zemdri (plazomicin) (Achaogen, Inc.): FDA Package Insert, Page 4
Achaogen: Rebound Likely In 2018 (OTCMKTS:AKAOQ-DEFUNCT-598977 ...
Events — Stanford Biotechnology Group
Get Started with BenchSci at Achaogen, Inc.
Achaogen's NDA For Plazomicin Gets Priority Review From FDA | Investing.com
Historical | ALSV
Axogen Announces FDA Approval - Start Medical Product Development
Axogen Announces FDA Approval of Biologics License Application for ...
Achaogen's Plazomicin Gets Breakthrough Therapy Designation | Investing.com
Банкротство Achaogen: показательная порка для всех антибиотиков ...
Achaogen's funding timeline | Download Scientific Diagram
Achaogen, Jun 2019
Hurdles of antibiotic R&D on display in Achaogen's divergent study ...
The Antibiotics Business Is Broken—But There's a Fix | WIRED
Slide 22
Biotech Forum Daily Digest For March 12th | Seeking Alpha
Outsourced Pharma San Francisco 2017 Agenda Update
Firmenliquidationen verschärfen die Antibiotika-Krise – infosperber
Time to Evolve: Addressing the Challenge of Carbapenem-Resistant ...
Antibiotic developer Nabriva to wind down
Achaogen’s bankruptcy and going-out-of-business sale offer a grim ...
Slide 19
Acciogen caja con 20 tabletas 200 mg / 500 mg | Walmart en línea
白塔科研 | 30年过去了，为什么没有研发出新的抗生素？ - 知乎
An Unlikely Biotech Investor: The Government
四环医药|收购Achaogen已上市新型抗生素大中华区权益！_手机搜狐网
The World Needs New Antibiotics. The Problem Is, No One Can Make Them ...
Antibiotic dealmaking poised for resurgence
Advancements in Plazomicin Antibiotic | PDF | Beta Lactamase | Bacteria
Plazomicin (Achaogen) financial post-mortem: #PassPASTEUR – AMR.Solutions
Проблемы в разработке антибиотиков
New clinical trial designs for evaluation of antimicrobial agents - 27 ...
四环3200万收购美股破产公司Achaogen新型抗生素 来源：格隆汇 药融圈 2月20日丨 四环医药 (00460.HK)发布公告，集团附属 ...
Biotech, health stocks dominate week's busy IPO calendar
2023_Duke-ISCVID_Criteria_for_Infective_Endocarditis__Updating_the ...
Case Studies
四环医药|收购Achaogen已上市新型抗生素大中华区权益！_治疗
groupaya
2018 Drug Resistance Conference GRC
.png)
